Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Commercial Officer
-
Stock Symbol
-
GH on Nasdaq
There are no Buy or Sell transactions made by Chris Freeman since 3/12/2024
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
38.8K |
$1.65M |
$42.55 |
Mar 1, 2025 |
Direct |
|
|
| Performance-Based Restricted Stock Units |
11.4K |
$534K |
$46.98 |
Mar 1, 2025 |
Direct |
Common Stock |
|
| Restricted Stock Units |
11.7K |
$357K |
$30.55 |
Jan 1, 2025 |
Direct |
Common Stock |
|
| Stock Option (Right to Buy) |
45.2K |
|
|
Nov 8, 2024 |
Direct |
Common Stock |
|
Transactions reported by Chris Freeman for Guardant Health, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.